201TlCl production process in proton accelerator facility in nuclear energy research institute.
Saved in:
| Title: | 201TlCl production process in proton accelerator facility in nuclear energy research institute. |
|---|---|
| Authors: | Yıldız Akdag, Berna1 (AUTHOR) Berna.Yildiz@tenmak.gov.tr |
| Source: | Journal of Radioanalytical & Nuclear Chemistry. Nov2023, Vol. 332 Issue 11, p4687-4693. 7p. |
| Subjects: | Proton accelerators, Nuclear facilities, Nuclear research, Manufacturing processes, Research institutes, Cyclotrons, Nuclear energy |
| Abstract: | In this manuscript, production of 201TlCl, one of the radiopharmaceuticals used in the field of nuclear medicine for diagnostic purposes in heart, muscle, thyroid gland imaging, and cancer diagnosis, at Turkish Energy Nuclear and Mineral Research Agency is described. The production process starts with a cyclotron type proton accelerator operated in energy range of 15–30 MeV with beam intensities up to 1200 μA currently available at the facility. The production is detailed along with the main lines in the other steps. In addition to the radiopharmaceutical productions carried out according to international standards at the facility, new projects are planned in the short and long terms. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Radioanalytical & Nuclear Chemistry is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | In this manuscript, production of 201TlCl, one of the radiopharmaceuticals used in the field of nuclear medicine for diagnostic purposes in heart, muscle, thyroid gland imaging, and cancer diagnosis, at Turkish Energy Nuclear and Mineral Research Agency is described. The production process starts with a cyclotron type proton accelerator operated in energy range of 15–30 MeV with beam intensities up to 1200 μA currently available at the facility. The production is detailed along with the main lines in the other steps. In addition to the radiopharmaceutical productions carried out according to international standards at the facility, new projects are planned in the short and long terms. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 02365731 |
| DOI: | 10.1007/s10967-023-08898-1 |
